Voya Investment Management LLC Regeneron Pharmaceuticals, Inc. Transaction History

Voya Investment Management LLC

  • $86.1 Billion
  • Q1 2024

A detailed history of Voya Investment Management LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 82,827 shares of REGN stock, worth $87.1 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
82,827
Previous 76,029 8.94%
Holding current value
$87.1 Million
Previous $66.8 Million 19.39%
% of portfolio
0.09%
Previous 0.08%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$902.69 - $993.35 $6.14 Million - $6.75 Million
6,798 Added 8.94%
82,827 $79.7 Million
Q4 2023

Feb 14, 2024
SELL
$775.18 - $881.7 $990,680 - $1.13 Million
-1,278 Reduced 1.65%
76,029 $66.8 Million
Q3 2023

Nov 14, 2023
SELL
$692.45 - $844.37 $1.93 Million - $2.36 Million
-2,793 Reduced 3.49%
77,307 $63.6 Million
Q2 2023

Aug 14, 2023
SELL
$700.03 - $830.35 $1.95 Million - $2.31 Million
-2,781 Reduced 3.36%
80,100 $57.6 Million
Q1 2023

May 15, 2023
SELL
$680.49 - $826.97 $8.1 Million - $9.84 Million
-11,902 Reduced 12.56%
82,881 $68.1 Million
Q4 2022

Feb 14, 2023
BUY
$705.89 - $766.39 $3.28 Million - $3.56 Million
4,650 Added 5.16%
94,783 $68.4 Million
Q3 2022

Mar 03, 2023
SELL
$573.97 - $724.32 $2.67 Million - $3.37 Million
-4,650 Reduced 4.91%
90,133 $62.1 Million
Q3 2022

Nov 14, 2022
BUY
$573.97 - $724.32 $22.3 Million - $28.2 Million
38,926 Added 76.02%
90,133 $62.1 Million
Q2 2022

Aug 15, 2022
BUY
$548.35 - $738.84 $690,921 - $930,938
1,260 Added 2.52%
51,207 $30.3 Million
Q1 2022

May 16, 2022
SELL
$595.12 - $698.43 $610,593 - $716,589
-1,026 Reduced 2.01%
49,947 $34.9 Million
Q4 2021

Feb 14, 2022
BUY
$543.48 - $670.97 $4.57 Million - $5.64 Million
8,407 Added 19.75%
50,973 $32.2 Million
Q3 2021

Nov 15, 2021
SELL
$574.03 - $680.96 $624,544 - $740,884
-1,088 Reduced 2.49%
42,566 $25.8 Million
Q2 2021

Aug 16, 2021
SELL
$472.8 - $558.54 $4.09 Million - $4.83 Million
-8,654 Reduced 16.54%
43,654 $24.4 Million
Q1 2021

May 17, 2021
SELL
$446.73 - $548.2 $1.76 Million - $2.16 Million
-3,933 Reduced 6.99%
52,308 $24.7 Million
Q4 2020

Feb 16, 2021
BUY
$478.3 - $607.98 $3.93 Million - $5 Million
8,216 Added 17.11%
56,241 $27.2 Million
Q3 2020

Nov 16, 2020
BUY
$544.75 - $658.21 $1.39 Million - $1.67 Million
2,543 Added 5.59%
48,025 $26.9 Million
Q2 2020

Aug 14, 2020
BUY
$493.32 - $643.92 $5.62 Million - $7.34 Million
11,398 Added 33.44%
45,482 $28.4 Million
Q1 2020

May 15, 2020
SELL
$336.18 - $494.43 $80,010 - $117,674
-238 Reduced 0.69%
34,084 $16.6 Million
Q4 2019

Feb 14, 2020
BUY
$274.13 - $376.51 $1.05 Million - $1.45 Million
3,843 Added 12.61%
34,322 $12.9 Million
Q3 2019

Nov 14, 2019
BUY
$273.46 - $318.39 $89,968 - $104,750
329 Added 1.09%
30,479 $8.46 Million
Q2 2019

Aug 14, 2019
BUY
$299.6 - $414.82 $224,999 - $311,529
751 Added 2.55%
30,150 $9.44 Million
Q1 2019

May 15, 2019
BUY
$372.08 - $439.57 $216,550 - $255,829
582 Added 2.02%
29,399 $12.1 Million
Q4 2018

Feb 14, 2019
BUY
$335.82 - $403.04 $36,604 - $43,931
109 Added 0.38%
28,817 $10.8 Million
Q3 2018

Nov 14, 2018
SELL
$351.14 - $408.51 $199,447 - $232,033
-568 Reduced 1.94%
28,708 $11.6 Million
Q2 2018

Aug 14, 2018
BUY
$284.6 - $344.99 $237,641 - $288,066
835 Added 2.94%
29,276 $10.1 Million
Q1 2018

May 15, 2018
SELL
$315.82 - $393.78 $81,481 - $101,595
-258 Reduced 0.9%
28,441 $9.79 Million
Q4 2017

Feb 14, 2018
SELL
$358.63 - $469.95 $398,079 - $521,644
-1,110 Reduced 3.72%
28,699 $10.8 Million
Q3 2017

Nov 14, 2017
BUY
$431.38 - $504.0 $12.9 Million - $15 Million
29,809
29,809 $13.3 Million

Others Institutions Holding REGN

# of Institutions
1,424
Shares Held
82.1M
Call Options Held
835K
Put Options Held
1.46M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $113B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email